Mathew John

ORCID: 0000-0002-6435-7995
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diabetes Management and Education
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Birth, Development, and Health
  • Growth Hormone and Insulin-like Growth Factors
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pharmacology and Obesity Treatment
  • Gestational Diabetes Research and Management
  • Thyroid Disorders and Treatments
  • Chronic Disease Management Strategies
  • Obesity and Health Practices
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diet and metabolism studies
  • Cardiac Arrhythmias and Treatments
  • Alzheimer's disease research and treatments
  • Adrenal Hormones and Disorders
  • Bariatric Surgery and Outcomes
  • Ion channel regulation and function
  • Pituitary Gland Disorders and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Pregnancy and preeclampsia studies
  • Infectious Encephalopathies and Encephalitis
  • Epilepsy research and treatment

Vellore Institute of Technology University
2024

Diabetes Care and Research Foundation
2023

Jubilee Mission Medical College and Research Institute
2022

St.John's Medical College Hospital
1990-2020

Providence College
2017-2020

Creative Commons
2020

Diabetes & Endocrine Associates
2020

Government Medical College
2020

Rajiv Gandhi Centre for Biotechnology
2019

KG Hospital
2013-2017

Background: Hypothyroidism is believed to be a common health issue in India, as it worldwide. However, there paucity of data on the prevalence hypothyroidism adult population India. Materials and Methods: A cross-sectional, multi-centre, epidemiological study was conducted eight major cities (Bangalore, Chennai, Delhi, Goa, Mumbai, Hyderabad, Ahmedabad Kolkata) India among population. Thyroid abnormalities were diagnosed basis laboratory results (serum FT3, FT4 Stimulating Hormone [TSH])....

10.4103/2230-8210.113755 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2013-01-01

Although several evidence-based guidelines for managing diabetes are available, few, if any, focus on the psychosocial aspects of this challenging condition. It is increasingly evident that treatment integral to a holistic approach diabetes; it forms key realizing appropriate biomedical outcomes. Dearth attention as much due lack awareness guidelines. This lacuna results in diversity among standards clinical practice, which, India, also size and complexity care itself. article aims highlight...

10.4103/2230-8210.111608 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2013-01-01

It was estimated that 3.2 million Indians with diabetes injected insulin in 2010, but little is known about the techniques used.In 2015 we conducted an injection technique questionnaire (ITQ) survey throughout India involving 1011 patients. Indian values were compared those from 41 other countries participating ITQ, here as rest of world (ROW).Mean HbA1c 8.6. BMI 1.5-3 units lower than ROW depending on patient group, meaning risk intramuscular (IM) injections high India. The mean total daily...

10.1007/s13300-017-0243-x article EN cc-by-nc Diabetes Therapy 2017-03-13

Background Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular India. Early T2DM diagnosis followed by appropriate management will result more cardiovascular event free life years. However, knowledge of the profile newly diagnosed patients is still limited. The aim this study was understand extent disease (CVD) risk Methods A cross sectional observational conducted evaluate clinical laboratory and socio-demographic parameters 5,080 (48.3 ± 12.8 years age; 36.7%...

10.1371/journal.pone.0263619 article EN cc-by PLoS ONE 2022-03-31

Using the Indian and rest of world (ROW) injection technique questionnaire (ITQ) data, we address key insulin complications.In 2015 conducted an ITQ survey throughout India involving 1011 patients. values were compared with those from 41 other countries participating in ITQ, known here as ROW.More than a quarter users described lesions consistent lipohypertrophy (LH) at their sites approximately 1 5 found to have LH by examining nurse (using visual inspection palpation). Just over half...

10.1007/s13300-017-0244-9 article EN cc-by-nc Diabetes Therapy 2017-03-13

Type 1 diabetes (T1D) is the most common form of in children Western countries. There have been no large studies childhood from India. We undertook MEDI study (Multicenter Survey Early Onset Diabetes India) to assess proportion various subtypes among young subjects presenting endocrinology divisions seven teaching hospitals different regions In addition, we compared clinical features T1D and type 2 (T2D) Indian subjects. Patients with onset disease at younger than 20 years age were included...

10.1196/annals.1447.056 article EN Annals of the New York Academy of Sciences 2008-12-01

Asia is home to four of the world's five largest diabetic populations, two them being South Asian nations, namely, India and Pakistan. This problem compounded by a substantial rise in elderly population countries. On other hand, heterogeneous health condition multiple co-morbidities make care chronic disease challenging task. The aim Consensus Guidelines provide evidence-based recommendations assist healthcare providers rational management type 2 diabetes mellitus population. Current used...

10.4103/2230-8210.81935 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2011-01-01

10.4103/2230-8210.83395 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2011-01-01

Patients with type 2 diabetes mellitus (T2DM) have increased risk of adverse events (AEs; e.g. dehydration, hypoglycaemia) in hot weather. This analysis assessed the efficacy and safety canagliflozin, a sodium glucose co-transporter (SGLT2) inhibitor, patients T2DM who live climates.This post hoc evaluated using pooled data from four 26-week, placebo-controlled studies (N=2,313) 104-week, active-controlled study (add-on to metformin vs glimepiride; N=1,450). Changes HbA1c, fasting plasma...

10.1111/ijcp.12868 article EN International Journal of Clinical Practice 2016-09-01

Type 2 diabetes is characterized by progressive beta-cell failure that results in sequential adding of different oral and injectable medications to achieve optimal glycemic control.[12] This necessitates administration multiple tablets or pills good control as the disease progresses.[2] In addition, subjects with type may have other co-morbidities such dyslipidemia, hypertension cardiovascular disease, which further increase burden medications. Polypharmacy increased pill dosing frequency...

10.4103/2230-8210.152739 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2015-01-01
Coming Soon ...